Lubrizol's Apinovex™ Polymer Wins CPhI China's 2025 Pharma Excipient Award
Apinovex™ polymer's win places it alongside another Lubrizol novel excipient, Apisolex™ polymer, with multiple awards, including CPhI's 2023 Global Innovation Award and recognition as the Grand Winner of the 2023 Annual Medicine Maker Innovation Award.
Share
Apinovex polymer's win places it alongside another of Lubrizol's novel excipients, Apisolex™ polymer, with multiple awards, including CPhI's 2023 Global Innovation Award and recognition as the Grand Winner of the 2023 Annual Medicine Maker Innovation Award. These awards underscore Lubrizol's commitment to bringing the next generation of excipient technology to market, improving solubility and bioavailability of APIs to enhance drug delivery.
'We are excited to have received this additional recognition from CPhI following the earlier receipt of innovation awards for our novel injectable excipient, Apisolex™ polymer,' says Matt Finkelhor, Global Commercial Manager, Novel Polymers, Lubrizol. 'The awards confirm that Lubrizol's innovation is making a difference in drug delivery solutions that improve bioavailability to help bring more life-changing medications to market.'
The CPhI awards include nine award categories across the entire pharmaceutical industry, fully showcasing outstanding achievements in innovation, design, ingredients and excipients. The Pharma Excipients Award recognizes innovative products with high market potential, focusing on improving the technical standards of the pharmaceutical excipients industry, shaping outstanding examples in the global pharmaceutical excipients field, and leading to new trends in industry development.
About Lubrizol
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with over 100 manufacturing facilities, sales and technical offices and over 7,000 employees worldwide. For more information, visit www.lubrizol.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Penguin Solutions Completes Redomiciliation to the United States
MILPITAS, Calif., June 30, 2025--(BUSINESS WIRE)--Penguin Solutions, Inc., a Delaware corporation (Nasdaq: PENG) ("Penguin Solutions" or the "Company") today announced the completion of the redomiciliation process to change the parent company of the Penguin Solutions group of companies from a Cayman Islands company to a Delaware corporation. The redomiciliation was accomplished by way of a Cayman Islands Scheme of Arrangement and was approved by an overwhelming majority of Penguin Solutions' shareholders at a Scheme Meeting held on June 16, 2025. The Grand Court of the Cayman Islands sanctioned the Scheme on June 25, 2025, and on the same date, the Scheme of Arrangement became effective in accordance with its terms upon the delivery of the Sanction Order to the Cayman Islands Registrar of Companies. The redomiciliation was completed following the close of trading on June 30, 2025. At completion, all issued ordinary shares and preferred shares of Penguin Solutions, Inc., a Cayman Islands exempted company ("Penguin Solutions Cayman"), were exchanged on a one-for-one basis for newly issued shares of common stock and shares of preferred stock, respectively, of the Company. The former shareholders of Penguin Solutions Cayman are now the stockholders of the Company, which is the parent company of the Penguin Solutions group of companies. The common stock of the Company will begin trading on the Nasdaq Global Select Market on July 1, 2025, with its trading symbol of "PENG" remaining unchanged. The Company does not anticipate any material impact to its employees or its day-to-day business as a result of the completion of the redomiciliation. For more information on the redomiciliation of the Company, please refer to a copy of the Sanction Order issued by the Grand Court of the Cayman Islands which approved the redomiciliation, available under the Governance section of our Investor Relations website. About Penguin Solutions The most exciting technological advancements are also the most challenging for companies to adopt. At Penguin Solutions, we support our customers in achieving their ambitions across our Advanced Computing, Integrated Memory, and Optimized LED business segments. With our expert skills, experience, and partnerships, we turn our customers' most complex challenges into compelling opportunities. For more information, visit View source version on Contacts Investor Contact Suzanne SchmidtInvestor Relations(510) 360-8596ir@ PR Contact Maureen O'LearyPenguin Solutions Corporate Communications(602) 330-6846pr@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Los Angeles Times
2 hours ago
- Los Angeles Times
Vera Clinic Becomes Official Hair Transplant Partner of the Houston Rockets
Vera Clinic, Europe's leading center for hair transplantation and regenerative medicine, is now the official hair transplant partner of the Houston Rockets, one of the most iconic members of the National Basketball Association (NBA). Launching in July 2025 and continuing throughout the 2025-2026 NBA season, this collaboration marks a milestone in connecting elite healthcare with elite sports. This is more than a partnership. This is about trust. This is about quality. This is about showing the world what happens when science, innovation, and ethics unite on a global stage. Sport and medicine seem worlds apart. But at the highest level, they speak the same language: precision, perfection and performance. This alliance is built on a shared mission: ✔️ To lead with integrity ✔️ To perform at the highest level ✔️ To earn global trust, one result at a time 'This powerful alliance is a statement of trust. Just as athletes depend on consistency and excellence, so do Vera Clinic's patients,' said a spokesperson from the Houston Rockets. 'We're proud to welcome them as an official partner and look forward to building a shared story of excellence and trust.' 'Partnering with the Houston Rockets is a reflection of what we've built over the last decade,' said Kazım Sipahi, founder of Vera Clinic.'From day one, we've prioritized transparency, science, and ethical care. To be acknowledged by an institution like the Rockets means our standard is global.' Vera Clinic was awarded the prestigious European Medicine Award for its commitment to clinical transparency, innovation, and patient-centered care. With over 40,000 patients from more than 80 countries, it has become a global destination for those seeking natural-looking hair restoration, built on real procedures, advanced technology and innovative techniques that consistently deliver beyond expectations. At the Houston Rockets, we know that trust isn't given – it's built. Game by game. Season by season. And Vera Clinic operates the same way: with relentless discipline, medical transparency and proven outcomes that stand the test of time. Founded in Istanbul, Türkiye Vera Clinic is a multi-award-winning medical center specializing in hair transplantation, with a special focus on personalized solutions, high-density grafting, and natural-looking results. The clinic has been featured in the Reuters, USA Today, Bustle and international rankings, and is known for its 18-month growth guarantee and patient-centered approach. Vera Clinic founded Sapphire FUE and created Oxycure™ Therapy – setting new standards in hair restoration with faster recovery, real science, and results trusted worldwide. Backed by Science. Endorsed by Champions Let the world see what trust looks like! Address: Kordonboyu, Turgut Özal Blv. No: 47,34860 Kartal/İ @veraclinicFacebook: @VeraClinicYouTube: @VeraClinicTikTok: @veraclinicWhatsApp: +90 555 888 81 23
Business Wire
2 hours ago
- Business Wire
Swisslog Healthcare Welcomes New Global Head of People & Organization
BROOMFIELD, Colo.--(BUSINESS WIRE)-- Swisslog Healthcare, a leading supplier in transport and pharmacy automation solutions, appoints Sarah Stary as the new Global Head of People & Organization. Stary brings over 18 years of global experience in human resources strategy, organizational development, and culture transformation to the role. In her new role, Stary will develop and execute people-centric strategies that support business growth, enhance organizational effectiveness, and drive a culture of engagement and inclusion. She will leverage her extensive experience in executive consulting, talent management, and leadership development to strengthen Swisslog Healthcare's workforce. "Swisslog Healthcare's mission to shape the future of healthcare automation aligns with my passion for developing high-performing teams," said Sarah Stary, Global Head of People & Organization at Swisslog Healthcare. "My focus will be on creating an environment where our talented workforce can innovate and deliver exceptional value to our customers and patients worldwide." 'I am excited to welcome Sarah on board. Her proven track record of building high-performing teams and cultures in global organizations combined with her strategic mindset, will be invaluable to our organization as we continue to grow and evolve. We look forward to her leadership in shaping our people strategy for the future,' said Cory Kwarta, CEO of Swisslog Healthcare. Prior to joining Swisslog Healthcare, Stary served as Human Resources Director EMEA at Trina Solar AG, where she led strategic HR initiatives across Europe, the Middle East, and Africa. She successfully managed mergers & acquisitions integrations, HR system implementations, and compliance management, aligning with global business objectives. Stary holds an Executive MBA from IE Business School, a Master's in Strategic HR Management from Bocconi University, and certifications in Coaching and Organizational Effectiveness from the University of Cambridge. Sarah is multi-lingual as she is fluent in German, English, and Spanish, and has intermediate skills in French, Mandarin, and some basic Italian. About Swisslog Healthcare: Swisslog Healthcare provides pharmacy workflow automations through robotic solutions and operational technology that enable hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients' needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways. For more information, visit
